New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
YS Biopharma Co., Ltd.
YS
Shape
US Flag

NASDAQ

192M

Biotechnology

1.02USD
Shape0.09 ( 9.68%)
Market Open
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

-21%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

43%

Quote Panel

Shape
Updated October 29, 2024
1W % 1M % 3M % 1Y 60.31 %

Key Metrics

Shape
  • Market Cap

    192.09M


  • Shares Outstanding

    188.33M


  • Share in Float

    17.10M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    1.02


  • Average Volume

    130559


  • Beta

    0.536


  • Range

    0.3503-1.78


  • Industry

    Biotechnology


  • Website

    https://www.yishengbio.com


  • Sector

    Healthcare


Fundamentals

Shape

11.92x

P/E Ratio

2.21x

P/S Ratio

1.43x

P/B Ratio

1.2

Debt/Equity

-49.3%

Net Margin

$-0.6

EPS

How YS compares to sector?

P/E Ratio

Relative Strength

Shape

YS

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$827M

Shape39%

2025-Revenue

$1.09

Shape66%

2025-EPS

$193M

Shape-39%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.23

arrow
arrow

+1619%

0.22
vs 0.01

Q4.23

arrow
arrow

N/A

-0.16
vs -0.13

Q1.24

arrow
arrow

N/A

-0.08
vs NA

Q2.24

arrow
arrow

N/A

-0.09
vs -0.10

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.23

arrow
arrow

-50%

96.8M  vs 194.1M

Q4.23

arrow
arrow

-9%

165M  vs 181.6M

Q1.24

arrow
arrow

NA

21.9M  vs NA

Q2.24

arrow
arrow

-86%

24.3M  vs 176.3M

Return on EquityShape

status-upQoQ

Q2.22

arrow
arrow

-3%

-0.03
vs NA

Q3.22

arrow
arrow

-1%

-0.01
vs -0.03

Q4.22

arrow
arrow

NA

NA
vs -0.01

Q1.23

arrow
arrow

NA

NA
vs NA

Q2.23

arrow
arrow

-11%

-0.11
vs NA

Q3.23

arrow
arrow

-19%

-0.19
vs -0.11

Q4.23

arrow
arrow

-16%

-0.16
vs -0.19

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News